Helping to unlock the incredible potential of ATMPs

The incredible potential of cell and gene therapies has been well demonstrated. Unfortunately, these cutting-edge treatments struggle with practical and commercial viability. Lentitek is addressing these challenges by solving  manufacturing issues that can plague the production lentiviral vectors. Through the provision of world leading expertise and technologies we are enabling ATMP developers to solve production issues, overcome practical hurdles and ultimately bring these amazing life changing therapies to those that need them most.